| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
CEO |
• • – |
2003-09-03 |
4 |
A |
$6.32 |
$221,200 |
D/D |
35,000 |
35,000 |
|
- |
|
| DNDN |
Dendreon Corp |
CEO |
• • – |
2003-09-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
35,000 |
39,990 |
|
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-06-30 |
4 |
D |
$7.40 |
$1,463,454 |
D/D |
(197,764) |
432,263 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
457,263 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
23,292 |
23,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,878,441 |
3,803,906 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
20,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
17,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-01-18 |
4 |
B |
$5.37 |
$1,024,999 |
I/I |
190,875 |
3,994,781 |
2.64 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
6,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
67,569 |
68,861 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-06-30 |
4 |
D |
$9.71 |
$79,884 |
D/D |
(8,227) |
60,634 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(993,801) |
3,000,980 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
260,528 |
321,162 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-31 |
4 |
D |
$12.60 |
$140,150 |
D/D |
(11,123) |
310,039 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-01 |
4 |
AS |
$12.07 |
$128,665 |
D/D |
(10,000) |
300,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-02 |
4 |
AS |
$11.74 |
$117,381 |
D/D |
(10,000) |
290,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-04 |
4 |
AS |
$13.01 |
$130,108 |
D/D |
(10,000) |
280,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-05 |
4 |
AS |
$12.99 |
$129,875 |
D/D |
(10,000) |
270,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-13 |
4 |
AS |
$10.07 |
$100,714 |
D/D |
(10,000) |
260,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-14 |
4 |
AS |
$10.52 |
$105,200 |
D/D |
(10,000) |
250,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-12 |
4 |
AS |
$11.68 |
$116,842 |
D/D |
(10,000) |
240,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-13 |
4 |
AS |
$11.52 |
$115,169 |
D/D |
(10,000) |
230,039 |
0 |
% |
|
140 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
